Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 725 across all filing types
Latest filing 2025-03-13 Audit Report / Informat…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by Aprogen. It provides a summary of the audit opinion (unqualified/proper) and key financial highlights from the consolidated and separate financial statements for the fiscal year ending 2024-12-31. While it contains financial data, it is a regulatory notification announcing the submission of the audit report to the exchange, rather than the full annual report (10-K) itself. According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2024
2025-03-13 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Aprogen Inc. It contains the meeting date, location, agenda items (financial statements approval, director/auditor compensation), and detailed management information including board activity, director remuneration, and major shareholder transactions. This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the upcoming AGM and solicit their votes. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification.
2025-03-13 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company APROGEN. It outlines the date, location, and agenda items (such as financial statement approval and director remuneration) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2025-03-05 Korean
[기재정정]주권관련사채권의처분결정(종속회사의주요경영사항)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from the Korean DART system regarding a 'Correction Report' (정정신고) for a 'Decision on Disposal of Convertible Bonds' (주권 관련 사채권의 처분결정) by a subsidiary. This type of filing, which details changes to corporate financial transactions, asset disposals, and management decisions, falls under the category of general regulatory announcements. Since it does not fit into specific categories like M&A, dividends, or director dealings, it is classified as a Regulatory Filing (RNS).
2025-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including conversion price adjustments and collateral agreements, by a major shareholder and their special related parties. This falls under the 'Major Shareholding Notification' category.
2025-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, including special relationships, collateral agreements, and conversion price adjustments for convertible bonds. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-02-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.